Stem Cell Agency Invests $32M Towards SCI Treatment
May 29, 2014 17:09:43 GMT -8
Post by DJ on May 29, 2014 17:09:43 GMT -8
San Diego, CA – A promising treatment for patients with spinal cord injuries and a therapy aimed at helping HIV patients create an AIDS-resistant blood system were approved today by the state’s stem cell agency, the California Institute for Regenerative Medicine (CIRM).
Both are part of the agency’s Strategic Partnership program, which aims to attract more industry investment in research projects funded by the stem cell agency, and accelerate the most promising projects into clinical trials. Both companies will match the funds that they are getting from the agency.
Both are part of the agency’s Strategic Partnership program, which aims to attract more industry investment in research projects funded by the stem cell agency, and accelerate the most promising projects into clinical trials. Both companies will match the funds that they are getting from the agency.
Read more: Stem Cell Agency Invests $32 Million Toward Therapies For Spinal Cord Injury and HIV/AIDS